Boston Scientific Corporation (NYSE:BSX) stock is presently standing at about $23.61 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 22 analysts covering the company is $28.00, which suggests the stock could still rise over 16 percent. The highest analyst price target is $31.00, which implies a rally of 69 percent. And a quick view of analyst notes show that 12 are rating the stock a buy while 9 rate BSX a strong buy. There are 5 equity research firms advocating a Hold and 0 consider it Sell.
Argus analysts provided their view on Boston Scientific Corporation (NYSE:BSX) recently. The rating firm issued a Buy rating to this company in a research note released on Sep 01, 2016. Guggenheim analysts disclosed their opinion on Boston Scientific Corporation (NYSE:BSX) recently. The rating firm gave a Buy rating to this stock in a research note published on Jun 09, 2016. According to a research note disclosed on Oct 05, 2015, analysts at Raymond James have upped their rating on these shares from Outperform to Strong Buy.
Boston Scientific Corporation (NYSE:BSX) Transactions Roundup
Several insiders were part of recent insider activity for the stock. Its EVP, GC & Chief Admin Officer Pratt Timothy A. sold 6,195 company shares for $137000.78, in a transaction on 2017-01-09. Following the transaction, the EVP, GC & Chief Admin Officer is left with a stake of 137.78 shares, currently valued at $3253. Meanwhile, SVP and President, Endoscopy Pierce David A sold 10,232 shares worth $227000.56, through a transaction dated 2017-01-09. Following the completion of the transaction, the insider is left with a stake of 25,600 shares, amounting $604416. BSX EVP, GC & Chief Admin Officer Pratt Timothy A. also sold 26,726 shares, at a stock price of $20.48. This transaction occurred on 2016-12-01 totals $547000.35. After this transaction, the insider’s stake stands at 233,704 shares, with a market value of $5517751.
Executives hold 0.79 percent of the stock. Pete M. Nicholas is one of the biggest insider owners in Boston Scientific Corporation (NYSE:BSX), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 3,486,965 shares which have current market value of around $82327243.65.Mr. Michael F. Mahoney is another major inside shareholder in the company. The insider owns 1,601,858 shares as of 0.12%, currently worth $37819867.38. Mr. J. Raymond Elliott is ranked as third insider holder of the stock. This insider holds 603,676 shares with a market value around $14252790.36 as of recent close.
Boston Scientific Corporation (NYSE:BSX) Earnings Outlook
In Boston Scientific Corporation (NYSE:BSX)’s latest quarter, EPS moved to $0.27 from $0.27 in preceding quarter and revenues reached at $2,105.00M compared to $2,126.00M. Analysts had expected Boston Scientific Corporation (NYSE:BSX) to post net income of about $0.27 per share on $2,070.86M in revenue. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $0.29 to $0.32. That is compared with the $0.26 in EPS it reported during the same period a year ago.